User: Guest

  



DOMAIN EXPERT ENGAGEMENTS

Number of executives repeatedly engaged by snail & email outreach*

POOL + OUTREACH

10716

Interactions with Platform & by Email *

INTERACTIONS

1286

Unique # Participated *

PARTICIPANTS

321

Responses Validated *

VALIDATIONS

33

* Platform engagements are dynamic. Stats are published quarterly.


  •  CODE

  •  PAGES

  •  DATE

  •  PRICE

    $

  •  DATA EXHIBITS

    125


TABLE OF CONTENTS


   Pages :    | $

   Study Reliability and Reporting Limitations.....I-1  
   Disclaimers.....I-2
Data Interpretation & Reporting Level.....I-2
  
   Product Definitions and Scope of Study.....I-3  
   Growing Importance of Intracranial Stents in Neurovascular Disease.....II-1
Table 1: Global Neurovascular Intervention Market by Technique (2014): Percentage Share Breakdown for Embolization, Revascularization, Support Devices, and Mechanical Thrombectomy (includes corresponding Graph/Chart).....II-1
1$350
   The Global Intracranial Stents Market - Adversely Impacted by the SAMMPRIS
  Study.....II-2
1$100
   SAMMPRIS Study: An Insight.....II-31$100
   Rising Geriatric Population – A Major Growth Driver for the ICS Market.....II-4 1$100
   Table 2: Elderly Population (65+ Years) as a Percentage of the Total Population: 2000 & 2025 (includes corresponding Graph/Chart).....II-51$350
   Table 3: Global Population Statistics for the 65+ Age Group: 2012 (includes corresponding Graph/Chart).....II-61$350
   Table 4: Life Expectancy at Age 60 and 80 Years- (2010-2015), (2020-2025) & (2045-2050) (includes corresponding Graph/Chart).....II-7
Market Challenges.....II-7
Technological Challenges.....II-7
Safety and Efficacy.....II-7
1$350
   Regulatory Challenges.....II-8
Price Factor.....II-8
1$100
   APOLLO Stent System.....II-9
WILLIS® Intracranial Stent Graft System.....II-9
Neuroform EZ® Stent System.....II-9
Wingspan® Stent System.....II-9
1$100
   Self-Expandable LEO.....II-10
Micrus® Pharos™ Vitesse™ Intracranial Stent.....II-10
Solitaire AB Neurovascular Remodeling Device.....II-10
1$100
   Changing Lifestyle Conditions Stoking Risk of Cerebrovascular Diseases.....II-11
Rising Stroke Statistics – An Opportunity Indicator.....II-11
1$100
   Rising Number of Restenosis Cases Boosts Demand for Stenting.....II-12
Asians at Highest Risk of Intracranial Atherosclerosis Disease.....II-12
Cardiovascular Stent Manufacturers Diversify Into the Neurovascular Market.....II-12
1$100
   QMRA Facilitates Detection of In-stent Stenosis.....II-13
MNCs Weave Strategies to Tap Growth Centers in Emerging Markets.....II-13
1$100
   Medical Tourism Buoys Demand for Stenting Procedures in Emerging Nations.....II-14
Rising Road Accidents Lead to Increasing Number of Stenting Procedures.....II-14
1$100
   Table 5: Global Rate of Road Fatalities by Economic Status of Countries (2014): Percentage Rate of Road Fatalities per 100,000 Residents for Low, Mid and High Per Capita Income Regions (includes corresponding Graph/Chart).....II-151$350
   Intracranial Stenting.....II-16
Stents.....II-16
Evolution.....II-16
1$100
   Types of Stents.....II-17
Bare Metal Stents (BMS).....II-17
Drug Eluting Stents.....II-17
1$100
   Self-Expanding Stents.....II-18
Post-Treatment Management.....II-18
Anti-Platelet Therapy.....II-18
1$100
   Surveillance Imaging.....II-191$100
   Introduction.....II-20
Diagnosis of Intracranial Stenosis.....II-20
Differential Diagnosis.....II-20
1$100
   Neuroimaging Screening.....II-21
Anatomic Diagnosis.....II-21
Digital Subtraction Angiography.....II-21
Transcranial Doppler.....II-21
Magnetic Resonance Angiography (MRA).....II-21
1$100
   Positron Emission Tomography (PET).....II-22
Computerized Tomography (CT) Perfusion.....II-22
Treatment Procedures for Intracranial Stenosis.....II-22
Medication.....II-22
Anticoagulants or Blood Thinners.....II-22
Cholesterol Lowering Drugs.....II-22
1$100
   Blood Pressure Medications.....II-23
Surgical Procedures.....II-23
Stenting/Balloon Angioplasty.....II-23
Cerebral Artery Bypass.....II-23
1$100
   Ischemic Stroke.....II-24
Symptoms, Indications, and Complications Associated with Stroke.....II-24
Posterior Circulation Stroke.....II-24
Anterior Circulation Stroke.....II-24
Non-Specific Signs.....II-24
Some Major Risk Factors for Stroke.....II-24
1$100
   Intracranial Atherosclerotic Disease (ICAD).....II-25
Risk Factors.....II-25
Treatment Options for ICAD.....II-25
1$100
   Brain Aneurysms/Cerebral Aneurysm/ Intracranial Aneurysm.....II-26
Aneurysm – Quick Facts.....II-26
Symptoms of Unruptured Aneurysm.....II-26
Risk Factors for Aneurysm.....II-26
1$100
   Detection Methods.....II-27
Table 6: Comparison of Sensitivity and Specificity of Computed Tomography Angiography (CTA), Transcranial Doppler Sonography (TCD) and Magnetic Resonance Angiography (MRA) in the Diagnosis of Intracranial Aneurysms (includes corresponding Graph/Chart).....II-27
1$350
   Table 7: Percentage Mortality, Morbidity, and Re-bleeding Rate of Intervention Associated with Intracranial Aneurysms.....II-28
Arterial Dissection.....II-28
Diagnosis.....II-28
Treatment.....II-28
Restenosis.....II-28
1$350
   CFDA Approves New Specifications of MicroPort’s Apollo Stent System (China).....II-29
MicroPort’s WILLIS® Intracranial Stent Graft System Receives China SFDA
  Approval.....II-29
Phenox’s pCONus Bifurcation Aneurysm Implant Obtains CE-Mark Approval.....II-29
Acandis’ Acclino 1.9-F Stent System Receives CE Mark Approval.....II-29
ITGI Medical Obtains CE Mark Approval for AneuGraft Nx.....II-29
1$100
   MicroVention Enrolls in Clinical Trial for Its FRED™ System (US).....II-30
Admedes Schuessler to Expand Nitinol Manufacturing Capacity.....II-30
STAR Study Results Establish Safety and Efficacy of Solitaire™ FR Device in Acute
  Ischemic Stroke Treatment.....II-30
MicroPort Scientific Announces Inauguration of MicroPort NeuroTech.....II-30
Purdue University Scientists Study Stents Coated with Nanotechnology-Enhanced Drug for
  Treatment of Aneurysms.....II-30
1$100
   Admedes Schuessler GmbH (Germany).....II-31
BALT Extrusion (France).....II-31
Cardiatis SA (Belgium).....II-31
1$100
   Codman & Shurtleff, Inc. (US).....II-32
Covidien PLC (Ireland).....II-32
1$100
   ITGI Medical Ltd. (Israel).....II-33
MicroPort Scientific Corporation (China).....II-33
1$100
   OBEX Medical (New Zealand).....II-34
Stryker Corp. (US).....II-34
1$100
   Table 8: World Recent Past, Current & Future Analysis for Intracranial Stents by Geographic Region - US, Europe and Rest of World Markets Independently Analyzed with Annual Sales Figures in US$ Thousand for the Years 2013 through 2020 (includes corresponding Graph/Chart).....II-351$350
   Table 9: World Historic Review for Intracranial Stents by Geographic Region - US, Europe and Rest of World Markets Independently Analyzed with Annual Sales Figures in US$ Thousand for the Years 2006 through 2012 (includes corresponding Graph/Chart).....II-361$350
   Table 10: World 14-Year Perspective for Intracranial Stents by Geographic Region - Percentage Breakdown of Dollar Sales for US, Europe and Rest of World Markets for the Years 2006, 2014 & 2020 (includes corresponding Graph/Chart).....II-371$350
   A. Market Analysis.....III-1
The Largest Market for Intracranial Stents Globally.....III-1
SAMMPRIS Study Results – A Major Blow to the US ICS Market.....III-1
2$190
   Ageing Demographics: A Key Market Driver.....III-3
Table 11: North American Elderly Population by Age Group: 1975-2050 (includes corresponding Graph/Chart).....III-3
1$200
   Regulatory Status of Intracranial Stents in the United States.....III-4
Intracranial Stenting among Medicare Beneficiaries during the Years
  2006-2010.....III-4
Strategic Corporate Developments.....III-4
1$95
   Select Key Players.....III-52$190
   B. Market Analytics.....III-7
Table 12: The US Recent Past, Current & Future Analysis for Intracranial Stents Market Analyzed with Annual Sales Figures in US$ Thousand for the Years 2013 through 2020 (includes corresponding Graph/Chart).....III-7
1$200
   Table 13: The US Historic Review for Intracranial Stents Market Analyzed with Annual Sales Figures in US$ Thousand for the Years 2006 through 2012 (includes corresponding Graph/Chart).....III-81$200
   A. Market Analysis.....III-9
Negative Effects of SAMMPRIS Study Expand to European Market.....III-9
Increasing Geriatric Population Segment: A Business Case for ICS.....III-9
1$200
   Table 14: Population Breakup by Age Group for Select European Countries: 2012 (As a % of Total Population) (includes corresponding Graph/Chart).....III-101$200
   Focus on Select Regional Markets.....III-11
France.....III-11
French Government Imposes Regulations on Advertisement of High-risk Medical
  Devices.....III-11
The United Kingdom.....III-11
Stroke Statistics in the UK.....III-11
Table 15: Breakdown of Total Number of Deaths Due to Strokes by Age and Sex in the UK: 2010 (includes corresponding Graph/Chart).....III-11
1$200
   Product Approvals.....III-12
Strategic Corporate Development.....III-12
Select Key Players.....III-12
2$190
   B. Market Analytics.....III-14
Table 16: European Recent Past, Current & Future Analysis for Intracranial Stents Market Analyzed with Annual Sales Figures in US$ Thousand for the Years 2013 through 2020 (includes corresponding Graph/Chart).....III-14
1$200
   Table 17: European Historic Review for Intracranial Stents Market Analyzed with Annual Sales Figures in US$ Thousand for the Years 2006 through 2012 (includes corresponding Graph/Chart).....III-151$200
   A. Market Analysis.....III-16
Developing Regions Poised to Witness Faster Growth.....III-16
Price Sensitivity of Asian Consumers – A Crucial Factor.....III-16
India & China Offer Significant Growth Opportunities.....III-16
1$190
   Table 18: China and India Leads Global Population (July 2013): Table Depicting China and India’s Huge Population Vis-a-vis Other Countries’ Population (in Million) by Age Group (includes corresponding Graph/Chart).....III-171$200
   Table 19: Age-wise Breakup of China and India’s Population Vis-à-vis Other Populous Countries Globally: As of July 2013 (includes corresponding Graph/Chart).....III-18
Select Regional Markets.....III-18
Australia.....III-18
Stroke Statistics in Australia.....III-18
1$200
   Table 20: Stroke Prevalence in Australia Age and Gender: 2012 (includes corresponding Graph/Chart).....III-19
Leading Risk Factors for Stroke-Related Fatalities: Ranking Based on Number
  of Deaths (2012).....III-19
China.....III-19
Healthcare Reforms and New Product Approval to Propel Market Growth.....III-19
1$200
   Table 21: Chinese Neurovascular Stents Market by Leading Brand (2013): Percentage Market Share Breakdown of Units Sold for Apollo, Wingspan, and Others (includes corresponding Graph/Chart).....III-20
APOLLO – Tried and tested Stent System.....III-20
WILLIS® to Target Bright Market Prospects in China.....III-20
1$200
   India.....III-21
Changes in Lifestyle Demographic and Socioeconomic Factors Increase Stroke
  Prevalence.....III-21
Stroke Statistics.....III-21
Management and Treatment of Stroke Presents a Daunting Task.....III-21
Kerala – Gaining Prominence for Neurovascular Therapy.....III-21
1$95
   Japan.....III-22
Japanese Intracranial Stents Market.....III-22
Table 22: Japanese Elderly (65+ Years) Population: 2000-2020 (includes corresponding Graph/Chart).....III-22
1$200
   Studies Validate Effectiveness of Endovascular Therapy for Treatment of
  Intracranial Aneurysm.....III-23
Product Approvals.....III-23
1$95
   Strategic Corporate Development.....III-24
Select Key Players.....III-24
2$190
   B. Market Analytics.....III-26
Table 23: Rest of World Recent Past, Current & Future Analysis for Intracranial Stents Market Analyzed with Annual Sales Figures in US$ Thousand for the Years 2013 through 2020 (includes corresponding Graph/Chart).....III-26
1$200
   Table 24: Rest of World Historic Review for Intracranial Stents Market Analyzed with Annual Sales Figures in US$ Thousand for the Years 2006 through 2012 (includes corresponding Graph/Chart).....III-271$200
    
 
 


Sales queries: Sales@StrategyR.com
Research queries: Info411@StrategyR.com